Optimizing Patient Care Through the Use of Clinical Pathways and Standard Operating Procedures When Treating Patients with Systemic AL Amyloidosis

Beginning with a comprehensive, multidisciplinary evaluation leading to treatment of patients with high dose melphalan (HDM) and autologous stem cell transplantation (SCT) requires excellent coordination of care, clear communication and collaboration within the team. The use of clinical pathways (CPs) provide direction in delivering precise and intentional care for a specific patient population. CPs were first used in a hospital setting in the 1980's in response to changes in healthcare, shifting the focus from volume to quality.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Source Type: research